Autonomous Therapy System Market is projected to reach a value of $3.41 billion by 2030.

According to the report published by Virtue Market Research, the Global Autonomous Therapy System Market was valued at $1.64 billion in 2022 and is projected to reach a market capitalization of $3.41 billion by 2030. Over the forecast period of 2023-2030, the market is anticipated to grow at a CAGR of 9.6% owing to a rise in the prevalence of mental health.

Read More @ https://virtuemarketresearch.com/report/autonomous-therapy-system-market

There is a global shortage of mental health professionals, especially in rural and remote areas. More than half of American counties, according to the National Institute of Mental Health, lack a professional psychiatrist, psychologist, or social worker. Long wait periods for therapy appointments as a result of this lack might worsen mental health disorders. This problem is addressed by the ATS market, which offers patients, wherever they may be on-demand mental health care without the requirement of a physical therapist.

On a worldwide level, there is an increase in the prevalence of mental health problems such as anxiety, depression, and PTSD. About one in four people globally, according to the World Health Organization, may have mental or neurological disorders at some point in their lives. The increasing incidence of mental health conditions is increasing the demand for therapy services, especially ATS, which can offer patients conveniently accessible and effective treatment. One key market trend in the Autonomous Therapy System (ATS) market is the integration of virtual reality (VR) technology into therapy sessions. Virtual reality therapy involves the use of immersive technology to simulate real world environments and scenarios to help patients overcome various mental health issues. As the technology behind VR continues to improve and become more affordable, we can expect to see an increase in the adoption of VR-based therapies in the ATS market. The ability to grow the market to disadvantaged groups is one important market opportunity in the Autonomous Treatment System industry. Many people in underserved places, such as rural or low-income areas, have limited access to mental health care as mental health concerns continue to grow. This provides an opportunity for ATS providers to broaden their reach and deliver mental health services to folks who would not otherwise have access to traditional therapy choices. The market for Autonomous Treatment Systems (ATS) has experienced tremendous change as a result of the COVID-19 pandemic. Several people have seen a rise in stress, anxiety, and other mental health problems as a result of social isolation and lockdowns. As a result, there is now a huge increase in demand for ATS solutions due to a rise in the need for mental health services. Remote counselling options have become more popular as a result of the pandemic's temporary shutdown of mental health clinics and the restricted availability of in-person therapy sessions. Virtual therapy sessions are now available on ATS providers' platforms in response to this demand, enabling patients to continue getting mental health treatment without having to leave their homes.

Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/autonomous-therapy-system-market/request-sample

Segmentation Analysis:
The Global Autonomous Therapy System Market segmentation includes:

By Product:
• Rehabilitation Robots
• Surgical Robots
• Hospitals and Pharmacy Robots
• Emergency Response Robotics Systems
• Non-invasive radiosurgery Robots

The rehabilitation robot segment is likely to experience significant growth in the coming years. This is brought on by the rise in the occurrence of chronic illnesses, impairments, and injuries that call for rehabilitation therapy, as well as the desire for non-invasive, affordable rehabilitation options. The purpose of surgical robots is to provide more accuracy and control while assisting physicians during surgical operations. Hospitals and pharmacy robots are made to help medical staff with managing medicine delivery and inventory control. As the need for autonomous treatment systems rises across a variety of sectors, several product categories within the ATS market provide a diverse range of applications and solutions.

By Application:
• Laparoscopy
• Neurology, Special Education
• Orthopaedics Robotics System
• Others

The market for orthopaedic robotic systems is anticipated to expand significantly over the next few years. This is a result of the expanding requirement for precision and accuracy in these treatments together with the rising demand for orthopaedic surgery, such as joint replacements and spine surgeries. Applications of ATS technology are also used in neurology to identify and treat neurological conditions including stroke, Parkinson's disease, and Alzheimer's disease. ATS technology is used in laparoscopy applications as well to help surgeons undertake minimally invasive procedures. Applications for special education utilise ATS technology to support the learning and development of people with impairments.

Regional Analysis:
In the years to come, the market for autonomous therapy systems (ATS) is anticipated to develop most rapidly in the Asia-Pacific area. Several factors include rising healthcare costs, an increase in the demand for cutting-edge medical technology, and an increase in the frequency of chronic illnesses. North America has the largest market for ATS, because there are many market participants there and because advanced technologies are widely used in the healthcare industry. Europe is the second largest market for ATS, driven by the rising incidence of chronic illnesses and disabilities, the ageing population, and the rising use of medical technologies. Latin America and the Middle East and Africa are also emerging markets for ATS, driven by increasing healthcare expenditure, the rising prevalence of chronic diseases, and the growing demand for advanced healthcare technologies.

Customize the Full Report Based on Your Requirements @ https://virtuemarketresearch.com/report/autonomous-therapy-system-market/customization

Latest Industry Developments:
• The CorPath GRX robotic system was launched in January 2022 and features advanced robotic and artificial intelligence technologies that allow for greater precision, accuracy, and control during PCI procedures. The system also allows for remote operation, which can reduce the risk of infection for both patients and healthcare professionals.

• In October 2021, Neuralink, a neurotechnology company founded by Elon Musk, announced that it had successfully implanted a wireless chip in a monkey's brain that allowed it to play video games using only its mind. The chip, called the N1 Link, is designed to allow people with disabilities to control computers and smartphones with their thoughts, potentially revolutionizing the field of autonomous therapy.

• The acquisition of Mazor Robotics by Medtronic, a renowned medical technology business, is one of the most recent events in the Autonomous Treatment System (ATS) sector. The transaction closed in February 2020 and is predicted to considerably strengthen Medtronic's position in the surgical robots industry.

Contact Us:

Virtue Market Research
Kumar Plaza, #103, SRPF Rd, Ramtekadi, Pune, Maharashtra 411013, India
E-mail: megha@virtuemarketresearch.com
Phone: +1-917 436 1025

Virtue Market Research is a strategic management firm helping companies to tackle most of their strategic issues and make informed decisions for their future growth. We offer syndicated reports and consulting services. Our reports are designed to provide insights on the constant flux in the global demand-supply gap of markets.

This release was published on openPR.